Diez, Alicia T.
HRN: 14-15-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/02/2025
11/08/2025
IVTT
2.25 G
Q6
Complicated Urinary Tract Infection, T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose Maximize Dose If With Normal EGFR
Final appropriateness: Yes
Overall appropriateness: Yes